Home Wellness Insights

19Aug

Peptides and Pregnancy: What to Avoid Before, During & After Pregnancy

Pregnancy Safety · GoalBMI Wellness

Pregnancy changes how medications are evaluated. Some weight-loss medications have specific pregnancy warnings, while many wellness peptides simply do not have enough human pregnancy data to establish safety.

Written by Karla K. Mioduchoski, FNP-BC | Medically reviewed by Dr. Rosemary Daly, D.O., DABPM

Quick answer: If you are pregnant, think you may be pregnant, or are trying to conceive, do not start or continue an elective weight-loss, recovery, anti-aging, or wellness peptide on your own. Contact your prescribing clinician and OB-GYN before making treatment changes.

Pregnancy is one of those times when we want patients to tell us about everything they are taking — prescriptions, compounded medications, peptides, supplements, and blends. If safety data are limited, we should not assume a product is safe simply because it is used for wellness.”

— Karla K. Mioduchoski, FNP-BC, GoalBMI Wellness

Peptides and pregnancy: what to avoid while pregnant – GoalBMI Wellness — Peptides and pregnancy safety overview from GoalBMI Wellness. Review any medication or peptide with your OB-GYN and prescribing clinician.

At a Glance

Contents show

Popular Peptides and Pregnancy

The evidence is different for each medication. Some have specific pregnancy labeling; others simply do not have enough reliable human data to establish safety.

Medication / Peptide	What We Know	Patient Takeaway
Semaglutide	Weight-loss treatment is not appropriate during pregnancy; planned pregnancy requires advance medication review.	Contact your provider if pregnant or planning pregnancy.
Tirzepatide	Current labeling warns of potential fetal harm and recommends discontinuation when pregnancy is recognized.	Do not use for intentional weight loss during pregnancy.
Tesamorelin	Pregnancy is a labeled contraindication.	Do not use during pregnancy.
Retatrutide	Investigational; pregnancy safety is not established.	Avoid elective use during pregnancy.
BPC-157	FDA reports no or limited human safety information.	Pregnancy safety is not established.
CJC-1295	Available clinical data are limited.	Avoid elective use during pregnancy.
Ipamorelin	FDA lacks sufficient safety information for certain injectable routes.	Pregnancy safety is not established.
TB-500	FDA reports no identified human drug-product exposure data for the TB-500 fragment.	Avoid elective use during pregnancy.
GHK-Cu injections	Limited human safety information for injectable use.	Do not assume pregnancy safety.
MOTS-c	FDA reports no identified human exposure data for drug products containing MOTS-c.	Pregnancy safety is not established.
Sermorelin	Adequate pregnancy safety evidence for elective wellness use is lacking.	Do not self-treat; discuss with your provider.

Weight-Loss Medications

Semaglutide, Tirzepatide and Retatrutide During Pregnancy

Semaglutide and Pregnancy

Intentional weight loss is not recommended during pregnancy. Planned pregnancy should be discussed before conception because semaglutide remains in the body for weeks.

Tirzepatide and Pregnancy

Tirzepatide should be discontinued when pregnancy is recognized under current weight-management labeling. Patients using it for diabetes need a clinician-directed glucose-management plan.

Retatrutide and Pregnancy

Retatrutide remains investigational. Pregnancy is not an appropriate setting for experimenting with an unapproved weight-loss compound.

Compounded Weight-Loss Medication

Compounded does not mean pregnancy-safe. A compounded product should not be assumed safer than an FDA-approved medication.

Body Composition

Tesamorelin and Pregnancy

Pregnancy is a contraindication in FDA-approved tesamorelin labeling. For general treatment safety information, see the GoalBMI Wellness Tesamorelin Side Effects guide.

Limited Human Data

BPC-157, CJC-1295, Ipamorelin, TB-500, GHK-Cu and MOTS-c

For many wellness peptides, the evidence problem is not that pregnancy trials proved harm. It is that adequate human safety information does not exist. Lack of evidence of harm is not evidence of safety.

BPC-157

FDA reports no or limited safety-related information for proposed routes of administration.

CJC-1295

Clinical data are limited, and FDA has identified serious adverse events associated with CJC-1295.

Ipamorelin

FDA lacks sufficient safety information for certain injectable routes.

TB-500

FDA reports no identified human drug-product exposure data for the TB-500 fragment.

GHK-Cu

Injectable GHK-Cu has limited human safety information and should not be confused with topical cosmetic products.

MOTS-c

FDA reports no identified human exposure data for drug products containing MOTS-c.

The absence of pregnancy studies is not reassurance. When a peptide has limited human reproductive safety data, the safest approach is to review the exact product with the patient’s prescribing clinician and OB-GYN rather than relying on assumptions or online experience.”

— Dr. Rosemary Daly, D.O., DABPM

Growth-Hormone Signaling

Sermorelin and Pregnancy

Adequate pregnancy safety evidence for elective sermorelin wellness use is lacking. A lack of pregnancy data should not be interpreted as proof of safety.

Multi-Peptide Programs

GLOW, KLOW and Wolverine Blends During Pregnancy

Combination products create multiple exposures at once. If individual ingredients lack adequate pregnancy safety data, combining them does not make the blend better studied.

GLOW Mix Therapy KLOW Peptide Therapy Wolverine Blend All Peptide Therapy Programs

If Pregnancy Happens

What If You Become Pregnant While Taking a Peptide?

An accidental exposure does not automatically mean harm occurred. Contact your OB-GYN and prescribing clinician, and provide the exact product, dose, concentration, and date of your last dose. Tell them if it was compounded or part of a peptide blend.

Important: If a medication is treating diabetes or another medical condition, ask about an appropriate replacement plan rather than leaving the condition untreated.

Compounded Products

Are Compounded Peptides Safer During Pregnancy?

No. “Compounded” does not mean safer, gentler, or pregnancy-approved. Compounded products should not be assumed safer during pregnancy.

Peptides before, during and after pregnancy – GoalBMI Wellness — Peptide and medication decisions can differ while trying to conceive, during pregnancy and while breastfeeding.

Planning Ahead

Planning Pregnancy While Using Peptides

Medication review is best done before conception. Different medications leave the body at different rates, so do not apply one drug’s stop-before-pregnancy timeline to another.

After Delivery

Peptides and Breastfeeding Are a Separate Question

Pregnancy and breastfeeding are different exposure situations. Whether a medication reaches breast milk and how much reaches the infant must be considered separately.

FAQ

Peptides and Pregnancy FAQs

Can you take peptides while pregnant?

Do not start elective weight-loss, recovery, anti-aging, or wellness peptides during pregnancy without specific medical direction. Some have explicit pregnancy warnings; many others lack adequate human pregnancy safety data.

What if I took a peptide before I knew I was pregnant?

Contact your OB-GYN and prescribing clinician with the exact product, dose, concentration, and timing. Accidental exposure does not automatically mean fetal harm occurred.

Is BPC-157 safe during pregnancy?

Pregnancy safety has not been established. FDA reports no or limited human safety information for proposed routes of BPC-157 administration.

Is tesamorelin safe during pregnancy?

Pregnancy is a contraindication in FDA-approved tesamorelin labeling.

Are compounded peptides safer during pregnancy?

No. Compounded products should not be assumed safer during pregnancy simply because they are compounded.

Can I use peptides while breastfeeding?

Breastfeeding requires a separate medication-specific risk assessment. Discuss the exact product and formulation with your healthcare provider.

Pregnancy, Peptides, Birth Control & Trying to Conceive

Can peptides affect fertility or make it easier to get pregnant?

It depends on the medication and the reason it is being used. Weight loss and improved metabolic health can sometimes change fertility, but that does not make a peptide a fertility treatment. If pregnancy is possible, discuss contraception and pregnancy planning with your provider before treatment.

Can tirzepatide make birth control pills less effective?

Yes. Tirzepatide delays gastric emptying and can reduce the effectiveness of oral hormonal contraceptives. Current Zepbound labeling advises switching to a non-oral contraceptive method or adding a barrier method for 4 weeks after starting tirzepatide and for 4 weeks after each dose increase.

What if I get pregnant while taking tirzepatide or semaglutide?

Contact your OB-GYN and prescribing clinician. Do not panic after an accidental early exposure. Your healthcare team can review the medication, dose, timing, medical indication, and available pregnancy data and help you decide what comes next.

How long before trying to conceive should I stop a weight-loss medication?

The answer depends on the medication because clearance times differ. Do not use one medication’s washout period for another. Review your pregnancy plans with the prescribing clinician before conception so you have a medication-specific plan.

Can I use BPC-157 while trying to conceive?

Human reproductive safety data for BPC-157 are inadequate, and there is no established evidence-based pregnancy washout period. If you are trying to conceive, discuss the peptide with your OB-GYN and prescribing clinician rather than assuming it is safe.

What about CJC-1295 or ipamorelin while trying to get pregnant?

Pregnancy safety has not been established for these wellness peptides. Limited general human safety information is another reason not to self-administer them while pregnant or trying to conceive.

Are peptide blends safer because the doses of each ingredient are smaller?

No. Combining several ingredients with limited pregnancy data does not establish safety. GLOW, KLOW, Wolverine and other blends should be reviewed ingredient by ingredient with your healthcare provider.

Can I restart peptides right after giving birth?

Not automatically. Postpartum care and breastfeeding create a new set of considerations. The right time to restart depends on the medication, why you use it, whether you are breastfeeding, and your overall recovery.

Can I take peptides while breastfeeding?

There is no single answer for every peptide. Lactation data are limited or absent for many wellness peptides, while approved medications may have product-specific information. Review the exact medication and formulation with your healthcare provider.

Are compounded peptides safer if my doctor prescribed them?

A prescription does not make a compounded product FDA-approved or establish pregnancy safety. Your provider can determine whether there is a medical reason to use a compounded medication, but pregnancy requires a separate benefit-risk discussion.

Related GoalBMI Wellness Resources

Peptide Therapy and Medication Information

Peptide Therapy in New York Semaglutide Programs Tirzepatide Programs Retatrutide Information

Evidence

Medical References

This article is based on current prescribing information and safety guidance from U.S. medical and regulatory sources. Pregnancy recommendations can change as new evidence becomes available, so patients should always review their specific medication with their OB-GYN and prescribing clinician.

FDA: Zepbound® (tirzepatide) Prescribing Information FDA: Safety Risks of Certain Compounded Peptide Substances FDA: Understanding the Risks of Compounded Drugs FDA: Compounding and FDA — Questions & Answers

Meet your peptide therapy provider at GoalBMI Wellness — Meet your GoalBMI Wellness peptide therapy provider for individualized treatment and medication review.

Pregnant, Trying to Conceive, or Have Questions About Your Medication?

Talk with your OB-GYN and prescribing clinician before starting, stopping, or changing treatment. GoalBMI Wellness patients can also speak with a licensed provider about their current medications and treatment plan.

Contact GoalBMI Wellness

Medical Disclaimer: This article is for educational purposes only and is not medical advice, diagnosis, obstetric care, or a recommendation to start or stop a medication. Pregnancy medication decisions should be made with your OB-GYN and prescribing healthcare professional.

Get Started

Book an appointment and take the first step toward better health.

Book Now

Related Weight Loss Programs